Endometriosis Now Takes 9 Years and 4 Months to Be Diagnosed
Endometriosis UK reports the average diagnosis time in Britain has risen to nine years and four months, up from eight years in 2020. The survey shows 39% of women needed ten or more GP visits before suspicion, while 55% presented at A&E, with 46% discharged without treatment. Around 1.5 million UK women live with the condition, which can cause systemic inflammation, infertility and severe pain. Advocacy groups are urging the government to cut diagnosis times to under one year by 2030 through funding, training and policy reforms.
Next-Gen Malaria Vaccine Overcomes Major Hurdle
Researchers at WEHI and the Burnet Institute have mapped the human immune response to Plasmodium vivax, revealing how antibodies neutralize the parasite. The study, published in Immunity, shows that protective immunity depends on antibody function and simultaneous targeting of multiple...
Mosaic Clinical Technologies Announces FDA Breakthrough Device Designation for Cognita’s Generative AI Model for Radiology
Mosaic Clinical Technologies announced that its AI unit Cognita received FDA Breakthrough Device Designation for Cognita Chest X‑Ray (CXR), the first generative vision‑language model in radiology to earn this status. The designation grants prioritized FDA interaction, potentially accelerating clearance. Internal...
GAIA and Daiichi Sankyo Europe Enter Exclusive Partnership to Launch Next-Generation Digital Therapeutic for Cardiovascular Care in Europe.
GAIA and Daiichi Sankyo Europe announced an exclusive partnership to commercialize lipodia, a digital therapeutic for hypercholesterolemia, pending regulatory approval. The agreement gives Daiichi Sankyo exclusive rights in Germany with plans to expand across Europe, leveraging GAIA’s evidence‑based platform and Daiichi’s cardiovascular...
Samoco Begins Prototyping Flagship Product with PHTA Makerspace
Samoco, a smart medical transport device firm, has begun prototyping its flagship blood‑preservation system in the PHTA Makerspace. The device actively cools and agitates blood during road or drone transport, aiming to keep units viable in hot, remote environments. Up...
Watch the Lean Hospitals Coach in Action — Live, Unscripted, With Your Questions
The author will host a LinkedIn Live demo on March 10 to showcase the Lean Hospitals Coach, an AI‑powered tool built around the *Lean Hospitals* book. The coach offers two query modes—Book Search with citations and Book Plus with broader Lean insights—and...
Tandem Mobi Now Compatible with Android Smartphones
Tandem Diabetes Care announced that its Tandem Mobi insulin pump is now compatible with Android smartphones in the United States via a newly released mobile app. The Android version received FDA clearance in November 2025 and entered a limited rollout in...
Menopause Hormone Therapy: The Myths, the Medicine, and the “Why Didn’t Anyone Tell Me?” Moment
The article debunks long‑standing myths about menopausal hormone therapy (MHT) by highlighting how the 2002 Women’s Health Initiative (WHI) trial was misapplied to all women. It explains that the WHI tested an older cohort using a specific estrogen‑progestin combo, leading...
![Rest Is a Holy Practice: Reclaiming the Soul of Medicine [PODCAST]](/cdn-cgi/image/width=1200,quality=75,format=auto,fit=cover/https://kevinmd.com/wp-content/uploads/Design-1-1-scaled.jpg)
Rest Is a Holy Practice: Reclaiming the Soul of Medicine [PODCAST]
Dr. Roxanne Almas, a developmental‑behavioral pediatrician, discusses how chronic burnout stems from medicine’s nonstop, transactional culture and shares her personal journey through grief and caregiving. She advocates for deep rest practices—such as Yoga Nidra, narrative medicine, and mindful pauses—to restore empathy,...
The Health System Opportunity Stack: A Builder’s Guide to the Most Underserved Enterprise in America
Health systems are drowning in operational blind spots, especially in financial operations, while existing software focuses on clinical documentation. The essay maps a high‑value opportunity stack—from payer‑contract intelligence and AP automation to workforce forecasting, OR utilization, and prior‑authorization automation—highlighting quantifiable...
FactChecking Claims in Casey Means’ Surgeon General Confirmation Hearing
During her March 2026 Senate confirmation, Dr. Casey Means faced intense questioning on vaccine policy, her professional credentials, and potential conflicts of interest. FactCheck.org examined the back‑and‑forth, verifying that her statements on vaccine safety aligned with CDC data and that...
Eton Pharmaceuticals Expands Rare Disease Portfolio with Acquisition of US Hemangeol Rights
Eton Pharmaceuticals has in‑licensed the U.S. commercialization rights to Hemangeol®, the sole FDA‑approved oral propranolol solution for infantile hemangioma, marking its tenth rare‑disease product. The hand‑off from Pierre Fabre is slated for May 1 2026, after which Eton will drive sales through its...
Talking Health Care Costs in Youngstown
Democratic lieutenant‑governor candidate David Pepper condemned Republican gubernatorial frontrunner Vivek Ramaswamy’s claim that Medicare and Medicaid are "mistakes" during a Youngstown news conference. Pepper highlighted that over 2.5 million Ohioans depend on Medicare and more than 3 million on Medicaid, arguing that...
A Fair Amount of ARPA-H Funding Is Being Used for Clinical Trials Relevant to Aging
ARPA‑H is committing up to $144 million to healthspan‑focused human trials through its PROSPR program, funding seven teams to develop early biomarkers and surrogate endpoints for aging interventions. The agency has awarded Cambrian Bio $30.8 million for an oral rapamycin analog targeting...
Oncolytic Virotherapies in Ovarian Cancer and NSCLC with Genelux CEO Thomas Zindrick — Episode 245
Genelux Corporation’s President and CEO Thomas Zindrick discussed the company’s oncolytic virotherapy programs targeting ovarian cancer and non‑small cell lung cancer on the Xtalks Life Science Podcast. The interview highlighted the therapeutic potential of engineered viruses to stimulate anti‑tumor immunity...
American Health Care Policy Reform: Why We Need a Bipartisan Commission
The United States is confronting a health‑care affordability crisis, with one‑third of citizens postponing care and 41 percent burdened by medical debt. Federal spending reached $5.3 trillion in 2024—about 18 % of GDP—and is projected to climb to $8.6 trillion by 2033. Public polls...
All Family Weekly Health Briefing
The FDA is reportedly reconsidering its stance on peptide compounds, a shift potentially driven by officials linked to Robert F. Kennedy Jr., which could broaden research and bio‑hacking applications. Meanwhile, ivermectin has re‑entered public discourse after high‑profile media mentions, prompting...
Rebuilding Patient Trust Through the Evolutionary Mismatch Framework
Board‑certified emergency physician Vikas Patel proposes the evolutionary mismatch framework to rebuild patient trust. He argues that modern chronic diseases stem from a gap between ancient human biology and today’s lifestyle, not from a broken body. By reframing illness as...
Magentus Launches UK Advisory Board to Strengthen Clinical Diagnostics Strategy
Magentus announced the creation of a UK Advisory Board composed of senior NHS figures such as Dame Barbara Hakin and Professors Ian Abbs and Erika Denton. The board will provide independent insight to shape product direction, align with NHS priorities...
Systemic Failure in Professional Environments: The Myth of Protection
The article argues that professional environments mistakenly equate contribution, credentials, and service with safety, exposing a systemic failure that spans health care, academia, law enforcement and corporate sectors. It uses the tragic case of Alex Pretti to illustrate how conditional...
Your Health System Was Not Built for You
A federal research team found that AI diagnostic tools are being applied to patients they were never designed for, often scoring cases before a doctor even enters the room. The study labeled the resulting errors as “catastrophic,” especially for patients...
Video Wednesday
On November 20, 2020, Verb and Johnson & Johnson unveiled OTTAVA, a six‑armed robotic platform designed for minimally invasive procedures. The system combines advanced haptic feedback with AI‑driven motion planning to enhance surgeon precision. Early trials suggest OTTADA can reduce operative time...
2025 Non-US Novel Large Molecule Drug Approvals
In 2025, Europe’s EMA, China’s NMPA, and Japan’s PMDA each granted first‑time approvals for novel large‑molecule therapeutics. Oncology accounted for the largest share of these approvals, while endocrinology—driven largely by GLP‑1‑based agents—was the second biggest category. The approvals span a...
VitalHub UK and CEMBooks Announce Partnership
VitalHub UK and CEMBooks have formed a partnership to deliver complementary digital tools for NHS operational insight and situational awareness. The collaboration combines VitalHub’s SHREWD system‑level platform with CEMBooks’ department‑focused management suite, allowing structured local capture alongside system‑wide oversight. Both...
The Blanket Sign: Recognizing Difficult Patient Encounters in the ER
In a candid ER column, Dr. George Issa describes the “Blanket Sign”—the tendency of adult patients who bring personal blankets to exhibit psychiatric or drug‑seeking behavior. He recounts a 42‑year‑old woman with chronic abdominal pain, opioid history, and a barrage...
FDA's History with Complex Plants
The FDA issued its first botanical drug guidance in 2004 and updated it in 2016, yet only four complex plant‑derived drugs have been approved to date. Ajna Biosciences, led by Joel Stanley, has secured clearance to begin a Phase 2 trial...
Vocxi Health and Forj Medical Partner to Miniaturise MyBreathPrint Device
Vocxi Health has teamed with Forj Medical to shrink its MyBreathPrint breath‑analysis system from a tabletop prototype to a handheld device the size of a deck of cards. The platform leverages graphene‑based nano sensors and AI‑driven algorithms to detect disease‑linked...
Harrison.ai Continues to Grow Open Platform Ecosystem, Welcomes Four New AI Partners
Harrison.ai announced that four AI companies—AIRAmed, Koios Medical, Lunit and Nanox AI—are joining its Open Platform, expanding the catalog of imaging solutions across X‑ray, CT, MRI, mammography and ultrasound. The platform maintains a vendor‑neutral, zero‑mark‑up model, allowing healthcare organizations to...
Sequana Medical Reports Strong U.S. Progress of Alfapump System
Sequana Medical reported that five leading U.S. hospitals have implanted its alfapump System since its Q4 2025 launch, including Mount Sinai, University of Pennsylvania, Dartmouth Hitchcock, and University Medical Center of Southern Nevada. The company is actively pursuing approvals to expand...
Is Unified Communications Failing Healthcare Delivery?
Healthcare providers have poured resources into unified communications platforms such as Microsoft Teams, yet the majority of frontline clinicians remain underserved by devices that cannot survive rigorous hygiene protocols or unreliable wireless coverage. While administrative staff benefit from modern UC...
Oren Nissim, Brook-Ai – Figuring Out RPM
Brook.ai, led by CEO Oren Nissim, is scaling its remote patient monitoring (RPM) platform to cut hospital readmissions and improve care plan adherence. The company reports over 50% of its hypertension cohort achieving control within ten weeks and a roughly...
Independent Medical Alliance Returns to Washington to Advance Patient and Parent-Centered Health Policy
The Independent Medical Alliance (IMA) returned to Washington, D.C. in early February 2026 for a series of meetings with senators, congressional staff, HHS officials and national media. Representing more than 12,000 clinicians across 35 specialties, IMA presented frontline clinical data...
GU26 Prostate Cancer Strategic Intelligence Report
Following strong interest in the ASH25 hematologic malignancy intelligence report, Biotech Strategy Blog released a new strategic intelligence series covering the ASCO GU meeting data on prostate, bladder, and renal cell cancers. The first installment focuses on advanced prostate cancer,...
The Future of Employer-Aligned DPC and Physician Autonomy
The article challenges the notion that Direct Primary Care (DPC) can thrive solely on individual consumer subscriptions, arguing that household‑income constraints limit universal demand. It highlights Bureau of Labor Statistics data showing modest health‑care spending capacity, especially for middle‑income families...
Pharma Pulse: FDA Grants Priority Review to Rusfertide and Expands Approval for Novo Nordisk’s Sogroya
The FDA granted priority review to Takeda’s rusfertide, a first‑in‑class hepcidin mimetic for polycythemia vera, after Phase III trials more than doubled response rates. A regulatory decision is expected in Q3 2026. The agency also expanded Novo Nordisk’s once‑weekly Sogroya to treat children...
Gynaecology Data Gaps Sees Women’s Health Suffer
The Medical Technology Group’s new report reveals that 42 Integrated Care Boards (ICBs) lack basic data on gynaecology pathways, waiting times, diagnoses and outcomes. More than 750,000 women are currently waiting for hospital gynaecology services, yet most ICBs do not...
Ascenti Physio Launches ‘Transformative’ Digital Physiotherapy App
UK independent provider Ascenti Physio has launched its Ascenti Reach digital physiotherapy app in a six‑month pilot with York and Scarborough Teaching Hospitals NHS Foundation Trust. Early data from other users show wait times can be cut by up to...
MyWay Digital Health Secures £3m to Scale NHS Diabetes Tool
Edinburgh‑based MyWay Digital Health has raised £3 million from Foresight Group to scale its clinically validated MyWay Diabetes platform, already deployed across several NHS regions. The funding will accelerate growth, broaden the product suite and fund AI‑enabled predictive analytics and personalized...
Medical Ethics and AI: Why Losing Oversight Endangers Patients
The American Medical Association’s Journal of Ethics published its final issue in December 2025, ending a 26‑year legacy of scholarly oversight. Simultaneously, the AMA launched a Center for Digital Health and Artificial Intelligence, signaling a strategic pivot toward technology. The...
What Every Sonographer and Cardiologist Must Know About CABG Patients
Cardiovascular disease remains the top global killer, accounting for 19.8 million deaths in 2022, with 85% linked to myocardial infarction or stroke. Echocardiography is essential for detecting ischemic cardiomyopathy, wall‑motion abnormalities, and left‑ventricular remodeling. Coronary artery bypass grafting (CABG) is a...
Access to National Healthcare Systems: The Deadline for Action Is Getting Closer
NHS England has set a firm deadline to retire the CIS1 authentication service, removing access on 28 February 2027 after reducing its SLA to silver on 1 October 2025. The move forces NHS trusts and other European hospitals to adopt the newer CIS2 platform,...
RecovryAI Announces FDA Breakthrough Device Designation for Patient-Facing Clinical AI
RecovryAI, emerging from stealth, received FDA Breakthrough Device Designation for its physician‑prescribed Virtual Care Assistants (VCAs), AI tools that guide patients through post‑operative recovery. The designation, reserved for devices that can substantially improve care standards, accelerates the company’s engagement with...
End-of-Life Care and Religion: Reconciling Jewish Law and Medicine
The essay examines how Jewish law’s reliance on legal fictions clashes with modern end‑of‑life medicine. It contrasts Halakha’s categorical certainty—viewing every moment of life as sacred—with medicine’s humility that prioritizes patient comfort and informed choice. While some rabbinic authorities allow...
Some Epigenetic Clocks Correlate with Risk of Dementia
A recent analysis of 6,069 cognitively normal women examined whether epigenetic aging clocks predict incident mild cognitive impairment or dementia. Second‑ and third‑generation clocks (AgeAccelPheno, AgeAccelGrim2, DunedinPACE) were compared with first‑generation Horvath and Hannum measures. Only the AgeAccelGrim2 clock showed...
Resilience Care & InterSystems Partner to Streamline Oncology Care Pathways
InterSystems and Resilience Care have formed a technology partnership to integrate Resilience Care’s remote‑monitoring platform with InterSystems IRIS for Health, streamlining oncology care pathways. The integration layer connects hospital information systems, automates data exchange for chemotherapy, lab, and imaging appointments,...
Industry Leaders Announce World’s First Microphysiological Systems Industry Association
Eight leading European microphysiological systems companies have launched the Industry Alliance for Microphysiological Systems (IAMPS), the world’s first trade association dedicated to MPS technologies. IAMPS will represent organ‑on‑chip, organoid and related NAM developers, aiming to harmonize standards, promote data sharing,...
Healthcare in 2026: Still Faxing, Already Talking About AI
The article highlights persistent low‑tech practices in 2026 healthcare—mis‑timed pharmacy texts, imaging still sent on physical CDs, and reliance on fax—while executives chase AI. It shows that simple fixes are known but remain unfixed due to cultural and governance gaps....
A Strong Dose of Digital for U.K. Pharma and Life Sciences
Earlier this year the UK government pledged £82.6 million to AI‑focused drug‑discovery firms, underscoring its ambition to lead the global digital health transformation. Major players such as AstraZeneca are launching dedicated health‑tech units like Evinova to accelerate clinical‑trial design, while the...
Latest TechBio News
Proscia has been crowned the top‑performing digital pathology software vendor in the United States, receiving a 95.2 overall score in KLAS Research’s 2026 report and earning A+ or A grades across all six customer‑experience pillars. The company is also the...
How Hands-On Medical Training Prepares You For Real Clinics?
Hands‑on medical assistant programs, like Allen School’s, immerse students in real‑clinic environments, letting them practice patient interviews, vital‑sign collection, and equipment use under supervision. Repeated simulations of appointment flow, teamwork, and electronic record entry turn theoretical knowledge into muscle memory...